Latest Stock Market News

Its consolidated revenue for the September quarter of FY23 stood at Rs 1,607 crore, up 9.9% as compared to Rs 1,462.5 crore in the corresponding period of the last fiscal. Its Q2FY23 hospital business revenues were at Rs 1,297 crore versus Rs 1,098.5 crore in Q2FY22.

Among Sensex stocks, Dr Reddy’s Labs, Sun Pharma, SBI, HUL and Reliance were the top losers, falling around 0.5-4%. Maruti, ICICI Bank, ITC, Tech Mahindra, TCS, L&T and Nestle also opened lower. On the other hand Power Grid Corp, Tata Steel, Kotak Bank, NTPC, M&M, Bajaj Finserv and Bajaj Finance opened with gains.

"If 18,200 survives, we could see 18,800 this week. Meanwhile, Nifty Bank, having already seen a new record peak, might slow down once it is in the vicinity of 42,500 , but looks poised for a long stretch of upsides aiming for 45,000 shortly. A fallback below 41740 will however negate such expectations."

Are FIIs having a crush on India in anticipation of a less aggressive policy stance by Fed Chair Jerome Powell in its December 13-14 meet? Analysts point out that the current phase of FII buying began when there were no signs of Powell calming down and both dollar and US bond yields were also rising.

The stock is trading close to overbought levels which could result in some profit taking but traders can look to buy the dip. The Supertrend indicator also triggered a buy on daily charts in November.

Macquarie maintained an outperform rating on HDFC Bank with a target price of Rs 2005. MSCI changes remove a major overhang, the brokerage said.

Given the lower life insurance penetration in the country as well as the multiple competitive moats which LIC has at its command, brokerage firm ICICI Direct initiated coverage on the stock and recommended a buy rating with a target price of Rs 917, suggesting an upside of 38%.

The Nifty Pharma index was trading 0.39 per cent down at 12964.6.

Emami Ltd., incorporated in the year 1983, is a Mid Cap company (having a market cap of Rs 20279.67 Crore) operating in FMCG sector.

Waller said markets should now pay attention to the "endpoint" of rate increases, not the pace of each move, and the endpoint is likely "a ways off," Waller said in remarks to an economic conference organized by UBS in Australia. "It depends on inflation.